Dr. Erkan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
535 E 70th St
New York, NY 10021Phone+1 212-774-2291Fax+1 212-774-2374
Education & Training
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1995 - 1998
Hacettepe University FOMClass of 1995
Certifications & Licensure
NY State Medical License 2001 - 2025
FL State Medical License 2012 - 2014- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome Start of enrollment: 2007 Sep 01
- Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients Start of enrollment: 2008 May 01
- Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE) Start of enrollment: 2010 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) "Damage" workin...Gustavo G M Balbi, Pedro Gaspar, Hannah Cohen, David A Isenberg, Doruk Erkan
Seminars in Arthritis and Rheumatism. 2025-02-01 - 2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria solid phase-based antiphospholipid antibody ...Pier Luigi Meroni, Maria Orietta Borghi, Olga Amengual, Tatsuyaa Atsumi, Maria Laura Bertolaccini
Journal of Thrombosis and Haemostasis. 2025-01-01 - Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision Analysis.Medha Barbhaiya, Stephane Zuily, Mary-Carmen Amigo, Danieli Andrade, Tadej Avcin
Arthritis Care & Research. 2024-12-01
Journal Articles
- Factors Associated with First Thrombosis in Patients Presenting with Obstetric Antiphospholipid Syndrome in APS Alliance for Clinical Trials & International Networking...Doruk Erkan, Michelle Petri, H Michael Belmont, Jason S Knight, BJOG: An International Journal of Obstetrics & Gynaecology
Lectures
- New Diagnostic and Treatment Strategies for Antiphospholipid Syndrome61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Other
- McMaster RARE‐Bestpractices Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid SyndromeDoruk Erkan, MD, Journal of Thrombosis and Haemostasis
https://www.doximity.com/articles/8ab28beb-5bfe-44a8-acbc-c9ce9270ef68
UpToDate, Wolters Kluwer Health - 2012-07-26 - McMaster RARE‐Bestpractices Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid SyndromeDoruk Erkan, MD, Journal of Thrombosis and Haemostasis
https://www.doximity.com/articles/8ab28beb-5bfe-44a8-acbc-c9ce9270ef68
UpToDate, Wolters Kluwer Health - 2012-08-13
Press Mentions
Novel Anti-NET Antibodies in a Multinational CohortMarch 28th, 2023- Updates on the ACR/EULAR Antiphospholipid SyndromeDecember 12th, 2022
- Exagen Inc. Announces a Collaboration with Hospital for Special Surgery (HSS) for Antiphospholipid SyndromeAugust 3rd, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
